Sichuan Kelun-Biotech Biopharmaceutical Co Ltd

Common Name
Sichuan Kelun-Biotech Biopharmaceutical
Country
China (Mainland)
Sector
Healthcare
Industry
Biotechnology
Employees
1,870
Ticker
6990
Exchange
HONG KONG EXCHANGES AND CLEARING LTD
Description
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. is a leading biopharmaceutical company engaged in the research, development, and manufacturing of innovative pharmaceutical products. The company focu...
GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Sichuan Kelun-Biotech Biopharmaceutical's GHG Emissions Data Preview

In 2023, Sichuan Kelun-Biotech Biopharmaceutical completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Sichuan Kelun-Biotech Biopharmaceutical has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2023202220212020 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Download Data

Verified Sources Behind Sichuan Kelun-Biotech Biopharmaceutical’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Sichuan Kelun-Biotech Biopharmaceutical’s data sources below and access millions more through our Disclosure Search.

a. Sichuan Kelun-Biotech Biopharmaceutical's Annual Report 2023
a. Sichuan Kelun-Biotech Biopharmaceutical's Annual Report 2023

Insights into Sichuan Kelun-Biotech Biopharmaceutical's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions of Sichuan Kelun-Biotech Biopharmaceutical amounted to 19,903.34 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Sichuan Kelun-Biotech Biopharmaceutical's Scope 1 Emissions Over Time

202302 k4 k6 k8 ktCO2e
  • Total Scope 1
  • Year-over-Year Change

What are Sichuan Kelun-Biotech Biopharmaceutical's Scope 1 emissions?

In 2023, the total Scope 1 emissions of Sichuan Kelun-Biotech Biopharmaceutical were 6,335.07 metric tons of CO₂ equivalent (tCO₂e). a

What are Sichuan Kelun-Biotech Biopharmaceutical's Scope 2 emissions?

In 2023, Sichuan Kelun-Biotech Biopharmaceutical reported Scope 2 greenhouse gas (GHG) emissions of 13,568.27 tCO₂e without specifying the calculation method. a

What methodology does Sichuan Kelun-Biotech Biopharmaceutical use for Scope 2 reporting?

In 2023, Sichuan Kelun-Biotech Biopharmaceutical reported its Scope 2 emissions using an unspecified methodology. a

Sichuan Kelun-Biotech Biopharmaceutical's Scope 2 Emissions Over Time

202303.5 k7 k10.5 k14 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Sichuan Kelun-Biotech Biopharmaceutical’s GHG Emissions Intensity Compared to Industry Peers

In 2023, Sichuan Kelun-Biotech Biopharmaceutical reported Scope 1 greenhouse gas (GHG) emissions of 6,335.07 tCO₂e and total revenues of USD 237 millions. This translates into an emissions intensity of 26.78 tCO₂e per millions USD. a

Sichuan Kelun-Biotech Biopharmaceutical's Scope 1 Emissions Intensity Compared to Peers

0.5102005,000100,000Scope 1 Emissions (tCO2e)2202002,00020,000Revenues (Millions of USD)AASInnoCare PharmaYear: 2023Scope 1: 20 tCO2eRevenue: $M 104Scope 1 Intensity: 0.19 tCO2e/$MAntengeneYear: 2023Scope 1: 45 tCO2eRevenue: $M 10Scope 1 Intensity: 4.37 tCO2e/$MShanghai Henlius BiotechYear: 2023Scope 1: 6,909 tCO2eRevenue: $M 830Scope 1 Intensity: 8.32 tCO2e/$MRemeGenYear: 2024Scope 1: 54 tCO2eRevenue: $M 234Scope 1 Intensity: 0.23 tCO2e/$MGenscript BiotechYear: 2024Scope 1: 39,377 tCO2eRevenue: $M 4,637Scope 1 Intensity: 8.49 tCO2e/$MAAAscentage PharmaYear: 2023Scope 1: 2,081 tCO2eRevenue: $M 34Scope 1 Intensity: 61.05 tCO2e/$MShanghai Junshi BiosciencesYear: 2024Scope 1: 5,308 tCO2eRevenue: $M 267Scope 1 Intensity: 19.88 tCO2e/$MEverest MedicinesYear: 2023Scope 1: 0 tCO2eRevenue: $M 19Scope 1 Intensity: 0.02 tCO2e/$MInnovent BiologicsYear: 2023Scope 1: 65 tCO2eRevenue: $M 953Scope 1 Intensity: 0.07 tCO2e/$MAkesoYear: 2024Scope 1: 6,408 tCO2eRevenue: $M 318Scope 1 Intensity: 20.17 tCO2e/$MAAAurisco PharmaceuticalYear: 2024Scope 1: 2,731 tCO2eRevenue: $M 202Scope 1 Intensity: 13.51 tCO2e/$MCARsgen Therapeutics HoldingsYear: 2021Scope 1: 117 tCO2eRevenue: $M 4Scope 1 Intensity: 28.91 tCO2e/$MZai LabYear: 2023Scope 1: 15 tCO2eRevenue: $M 267Scope 1 Intensity: 0.06 tCO2e/$MZhifeiYear: 2023Scope 1: 14,211 tCO2eRevenue: $M 7,446Scope 1 Intensity: 1.91 tCO2e/$MKintor PharmaceuticalYear: 2021Scope 1: 29 tCO2eRevenue: $M 5Scope 1 Intensity: 5.35 tCO2e/$MAscletis PharmaYear: 2023Scope 1: 422 tCO2eRevenue: $M 9Scope 1 Intensity: 48.50 tCO2e/$M3SBioYear: 2024Scope 1: 13,304 tCO2eRevenue: $M 1,364Scope 1 Intensity: 9.75 tCO2e/$MVIVA Biotech HoldingsYear: 2022Scope 1: 1,404 tCO2eRevenue: $M 373Scope 1 Intensity: 3.76 tCO2e/$MPharmaron BeijingYear: 2024Scope 1: 34,268 tCO2eRevenue: $M 1,682Scope 1 Intensity: 20.37 tCO2e/$MJacobio Pharmaceuticals GroupYear: 2023Scope 1: 34 tCO2eRevenue: $M 10Scope 1 Intensity: 3.48 tCO2e/$MAsymchem Laboratories (Tianjin)Year: 2023Scope 1: 46,854 tCO2eRevenue: $M 1,101Scope 1 Intensity: 42.55 tCO2e/$MWuXi Biologics (Cayman)Year: 2023Scope 1: 32,687 tCO2eRevenue: $M 2,603Scope 1 Intensity: 12.56 tCO2e/$MAlphamab OncologyYear: 2023Scope 1: 3,970 tCO2eRevenue: $M 34Scope 1 Intensity: 117.90 tCO2e/$MSSSichuan Kelun-Biotech BiopharmaceuticalYear: 2023Scope 1: 6,335 tCO2eRevenue: $M 237Scope 1 Intensity: 26.78 tCO2e/$M

How does Sichuan Kelun-Biotech Biopharmaceutical's GHG emissions intensity compare to its peers?

In 2023, Sichuan Kelun-Biotech Biopharmaceutical reported a Scope 1 emissions intensity of 26.78 tCO₂e per millions USD. Compared to the peer group median of 8.49 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a

Where does Sichuan Kelun-Biotech Biopharmaceutical rank on GHG emissions intensity within its industry?

In 2023, Sichuan Kelun-Biotech Biopharmaceutical ranked 19 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

This places Sichuan Kelun-Biotech Biopharmaceutical among the least efficient performers, with one of the highest emissions intensities in its sector. a

Want Full Access to Sichuan Kelun-Biotech Biopharmaceutical's GHG Emissions Dataset?
Sign Up

Explore Peer Companies

InnoCare Pharma Ltd

Healthcare
Biotechnology
China (Mainland)

Alphamab Oncology

Healthcare
Biotechnology
China (Mainland)

WuXi Biologics (Cayman) Inc

Healthcare
Biotechnology
China (Mainland)

Asymchem Laboratories (Tianjin) Co Ltd

Healthcare
Biotechnology
China (Mainland)

Jacobio Pharmaceuticals Group Co Ltd

Healthcare
Biotechnology
China (Mainland)

Pharmaron Beijing Co Ltd

Healthcare
Biotechnology
China (Mainland)